top of page
BETA logo.001.png

PROJECT TEAM

Fatemeh Makouei: Biomedical Engineer, Assistant Professor; Department of Otorhinolaryngology – Head and Neck Surgery & Audiology, Rigshospitalet

Tobias Todsen: Head and Neck Surgery Consultant, Associate Professor; Department of Otorhinolaryngology – Head and Neck Surgery & Audiology, Rigshospitalet

THE NEED

Inadequate surgical margins occur in up to 44% of oral cancer surgeries, increasing the risk of repeat treatment and reducing survival rates.

THE SOLUTION

3Sonic provides 3D ultrasound imaging of resected tumors in the OR, enabling immediate evaluation of surgical margins and more precise surgery.

3Sonic – Rigshospitalet

Call 2 – 2022 | Call 4 – 2023

GRANT: 2 x 500,000 DKK

Clinical Area

Tumor

Technology

3D Ultrasound Imaging

PROJECT SUMMARY

Oral cavity cancer is the second most common head and neck cancer in Denmark, and it accounts for approximately 900,000 cases worldwide each year. Surgery is the primary treatment, especially for younger patients and early-stage cancers.
Accurately identifying tumor boundaries during surgery is challenging, and up to 44% of patients have inadequate surgical margins. 3Sonic provides surgeons with a 3D ultrasound visualization of the resected tumor in the operating room, allowing real-time margin assessment.

This improves surgical precision, reduces the need for repeat surgery and radiotherapy, and leads to better patient outcomes. The method also holds potential for broader use in other soft-tissue cancers, expanding its clinical and societal impact.

CLINICAL IMPACT

3Sonic can improve survival and quality of life, reduce the need for additional treatments, and lower healthcare costs by freeing up resources.

bottom of page